Clinical Trials Browser

Phase 1 × Completed × LY3295668 erbumine × Clear all

NCT03898791 2021-08-05

A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Phase 1 Completed

Epilepsy, Small Cell Lung Carcinoma

NCT03955939 2020-06-01

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Phase 1 Completed

Breast Neoplasms, Epilepsy